Top Bioinformatics Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Bioinformatics Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Bioinformatics industry players.

Bioinformatics Market Competitive Landscape

The unprecedented global growth of genomic, proteomic, transcriptomic, and metabolomic data is the most powerful primary driver of the bioinformatics market. Continuous advances in next-generation sequencing (NGS), declining sequencing costs, and large-scale population genomics initiatives are generating petabytes of highly complex biological data every year. This massive data surge creates a direct cause-and-effect dependency on bioinformatics platforms, as traditional laboratory analysis alone cannot extract meaningful insights at such scale. As sequencing becomes routine in clinical diagnostics, oncology, and personalized medicine, healthcare institutions and research organizations are compelled to adopt advanced bioinformatics software, cloud-based analytics, and AI-driven data interpretation tools, directly accelerating market expansion.

Industry Overview

According to SkyQuest Technology “Global Bioinformatics Market” By Products & Services (Knowledge Management Tools, Bioinformatics Platforms), By Purchase Mode (Group Purchase, Individual Purchase), By Sector, By Region - Industry Forecast 2025-2032,” Global hydrogen market is projected to grow at a CAGR of over 13.2% by 2032, on account of urgent need for automating quantified data. The increasing scientific and financial complexity of modern drug discovery serves as a key factor reinforcing sustained bioinformatics market growth. Drug developers now focus on precision therapies, biologics, and rare disease treatments that require deep molecular and genetic validation.

Top 10 Global Bioinformatics Companies

Company

Est. Year

Headquarters

Revenue

Key Services

Illumina, Inc.

1998

San Diego, California

USD 4.30 billion (2024)

Next-generation DNA sequencing systems, genomic data analysis software, sequencing reagents & consumables, population genomics solutions, clinical genomics platforms

Thermo Fisher Scientific, Inc.

2006

Waltham, Massachusetts

USD 42.88 billion (2024)

Bioinformatics software platforms, genomic and proteomic data analysis, cloud-based life science analytics, laboratory informatics, drug discovery informatics

QIAGEN N.V.

1984

Hilden, Germany

USD 1.98 billion (2024)

Bioinformatics data analysis software, NGS data interpretation, clinical decision support tools, molecular diagnostics informatics, genomic workflow automation

Agilent Technologies, Inc.

1999

Santa Clara, California

USD 6.51 billion (2024)

Genomics and bioinformatics software, mass spectrometry data analysis, proteomics informatics, laboratory data management systems, molecular diagnostics analytics

PerkinElmer, Inc.

1937

Waltham, Massachusetts

USD 1.25 billion (2024)

Bioinformatics and imaging software, drug discovery informatics, genomic data analysis, laboratory information management systems (LIMS), clinical diagnostics analytics

Roche Holding AG

1896

Basel, Switzerland

USD 68.7 billion (2024)

Clinical bioinformatics platforms, genomic sequencing analytics, oncology informatics, digital pathology solutions, precision medicine data platforms

BGI Genomics Co. Ltd.

1999

Shenzhen, Guangdong

USD 540 million (2024)

Genome sequencing services, bioinformatics data analysis, population genomics services, clinical genomics solutions, agricultural and microbial genomics analytics

Genedata

1997

Basel, Switzerland

USD 106.6 million (2024)

Drug discovery bioinformatics platforms, biological data management, cheminformatics, proteomics and genomics analytics, enterprise R&D data integration

Dotmatics

2005

Boston, Massachusetts

NA

Scientific data management software, bioinformatics and cheminformatics platforms, R&D informatics, assay data analysis, drug discovery workflow tools

Computomics GmbH

2012

Tübingen, Germany

USD 8.4 million (2024)

Genomic data analysis services, breeding informatics, predictive bioinformatics for agriculture, microbial genomics, crop trait analysis platforms

1. Illumina, Inc.

Illumina, Inc. is a global leader in DNA sequencing and genomics technologies, playing a foundational role in the expansion of the global bioinformatics market. Founded in 1998 and headquartered in San Diego, California, the company supplies next-generation sequencing (NGS) platforms, reagents, and advanced bioinformatics software that enable large-scale genomic data generation and analysis. Illumina’s technologies are central to precision medicine, oncology research, population genomics, and clinical diagnostics. Through continuous innovation in high-throughput sequencing and cloud-based data analytics, Illumina directly drives demand for scalable bioinformatics solutions worldwide.

2. Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific, Inc. is a global life sciences and analytical technology leader with a strong influence on the global bioinformatics market through its integrated laboratory, genomic, and data analytics solutions. Founded in 2006 through the merger of Thermo Electron and Fisher Scientific and headquartered in Waltham, Massachusetts, the company delivers advanced bioinformatics software, cloud-based informatics, and genomic data analysis platforms that support drug discovery, clinical research, and precision medicine. Its end-to-end digital ecosystem enables researchers to manage, analyze, and interpret complex biological data at scale.

3. QIAGEN N.V.

QIAGEN N.V. is a leading global provider of molecular diagnostics and bioinformatics solutions, playing a critical role in the global bioinformatics market through its integrated sample-to-insight workflows. Founded in 1984 and headquartered in Hilden, Germany, the company delivers advanced bioinformatics software for NGS data analysis, clinical decision support, and molecular diagnostics interpretation. QIAGEN’s digital platforms support precision medicine, infectious disease testing, oncology, and translational research. By tightly combining wet-lab technologies with powerful bioinformatics tools, QIAGEN enables faster, more accurate biological insights across research and clinical settings worldwide.

4. Agilent Technologies, Inc.

Agilent Technologies, Inc. is a leading global provider of analytical instruments, laboratory software, and bioinformatics solutions that significantly support the global bioinformatics market. Founded in 1999 and headquartered in Santa Clara, California, the company delivers advanced genomics, proteomics, and mass spectrometry informatics platforms for life sciences research and clinical diagnostics. Agilent’s bioinformatics offerings enable high-precision data acquisition, interpretation, and integration across complex biological workflows. Its strong presence in pharmaceutical R&D, environmental testing, and clinical laboratories reinforces its role in enabling data-driven discovery and precision analytics worldwide.

5. PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader in diagnostics, life sciences, and analytical solutions, with a strong footprint in the global bioinformatics market through its advanced informatics and imaging platforms. Founded in 1937 and headquartered in Waltham, Massachusetts, the company provides bioinformatics software for genomics, proteomics, imaging analytics, and laboratory data management. PerkinElmer’s digital solutions support drug discovery, clinical diagnostics, and population health programs. By enabling high-throughput data analysis and integrated laboratory workflows, the company plays a vital role in accelerating data-driven research and precision medicine worldwide.

6. Roche Holding AG

Roche Holding AG is a global pharmaceutical and diagnostics powerhouse with a major influence on the global bioinformatics market through its strong focus on precision medicine and digital health. Founded in 1896 and headquartered in Basel, Switzerland, Roche integrates advanced bioinformatics across its diagnostics, oncology, and genomics platforms to enable data-driven disease detection and targeted therapy development. Through its diagnostics division and investments in genomic analytics, digital pathology, and clinical decision-support software, Roche plays a central role in translating complex biological data into actionable clinical insights worldwide.

7. BGI Genomics Co. Ltd.

BGI Genomics Co. Ltd. is a global leader in large-scale genome sequencing and bioinformatics services, playing a significant role in the expansion of the global bioinformatics market. Founded in 1999 and headquartered in Shenzhen, China, the company provides high-throughput sequencing, multi-omics analysis, and advanced bioinformatics services for medical research, clinical diagnostics, agriculture, and population genomics. BGI’s powerful data processing platforms support precision medicine, disease surveillance, and large national genomics initiatives. Its ability to combine massive sequencing capacity with deep bioinformatics expertise positions it as a key driver of data-driven life sciences worldwide.

8. Genedata

Genedata is a leading provider of enterprise bioinformatics software that plays a vital role in the global bioinformatics market by enabling data-driven drug discovery and life sciences research. Founded in 1997 and headquartered in Basel, Switzerland, the company delivers advanced platforms for biological data management, cheminformatics, genomics, and proteomics analytics. Genedata’s solutions are widely used by pharmaceutical and biotechnology companies to streamline R&D workflows, improve decision-making, and accelerate pipeline productivity. Its strong focus on scalable, high-performance data platforms supports the growing demand for complex, multi-omics-driven research worldwide.

9. Dotmatics

Dotmatics is a global provider of scientific R&D software that plays a significant role in the global bioinformatics and drug discovery informatics market. Founded in 2005 and headquartered in Boston, Massachusetts, the company delivers integrated bioinformatics and cheminformatics platforms that support data management, analysis, and collaboration across pharmaceutical and biotechnology research. Dotmatics’ solutions enable efficient handling of complex biological and chemical datasets across the full drug discovery lifecycle. By unifying experimental data, analytics, and digital workflows, the company helps accelerate innovation, improve research productivity, and reduce development timelines across life sciences organizations worldwide.

10. Computomics GmbH

Computomics GmbH is a specialized bioinformatics company that plays an important role in the global bioinformatics market through its focus on predictive genomics and agricultural biotechnology analytics. Founded in 2012 and headquartered in Tübingen, Germany, the company provides advanced genome analysis, crop and plant breeding informatics, and microbial genomics services. Computomics leverages machine learning and high-performance computing to extract actionable insights from complex genomic datasets. Its solutions support seed companies, agricultural researchers, and life science organizations in accelerating trait discovery and improving genetic performance through data-driven breeding strategies.

Other Leading Global Bioinformatics Companies

  • SOPHiA GENETICS
  • Seqera Labs
  • DNASTAR, Inc.
  • Fios Genomics
  • Partek Incorporated
  • Source BioScience
  • Biomax Informatics AG
  • Eurofins Scientific
  • NeoGenomics Laboratories
  • Waters Corporation

Conclusion

The global bioinformatics market is entering a phase of accelerated and sustained growth driven by the explosive expansion of multi-omics data and the increasing complexity of modern drug discovery. Rapid advances in next-generation sequencing, falling sequencing costs, and the routine use of genomics in clinical diagnostics have created a strong cause-and-effect dependence on scalable bioinformatics platforms. At the same time, the shift toward precision medicine, biologics, and rare disease research has made data-driven discovery indispensable for pharmaceutical and biotechnology companies. Leading players such as Illumina, Thermo Fisher Scientific, QIAGEN, and Roche are strengthening the ecosystem through continuous technological innovation and integrated digital workflows. Together, these forces ensure that bioinformatics will remain a critical infrastructure supporting future breakthroughs in healthcare, life sciences, and precision therapeutics worldwide.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

The CAGR is projected to be 13.24% between 2025 and 2032 for the global bioinformatics market. Growth will be driven by advances in personalized medicine, genomics and proteomics research, and increased support for genomic research efforts.

The bioinformatics market's largest segment is Knowledge Management Tools which was valued at USD 8.9 billion in 2024. Knowledge Management Tools consist of various systems and applications that organize, integrate, and interpret biological data, all of which are crucial in the research and pharmaceutical workforce.

Genomics has the largest application in bioinformatics, accounting for about 30% of the market share in 2024. This is due to the influx of next-generation sequencing data and the importance of genomics to personalized medicine and diagnostics, as well as large-scale genome projects.

AI is improving bioinformatics tools and platforms by improving the understanding of complex biological information, increasing the speed and accuracy of predictive modeling, variants analysis, and drug discovery. Tools like ExpasyGPT, allow researchers to create natural language queries across databases.

Cloud-based bioinformatics platforms are making the way in bioinformatics, increasing speed, scalability and cost-effectiveness for what can become incredibly large biological datasets. They allow for real time collaboration, data integration, and access to data, reducing the barrier to entry for many advanced bioinformatics tools.

North America is the leader in bioinformatics with a projected 43% market share in 2024. The U.S has one of the highest healthcare expenditures when compared to other countries and has extensive government support. The above factors have led to North America having some of the world's best biotechnology firms as well as having a heavy concentration of genomic research. The U.S. alone is expected to account for over 85% of the North American market.

Asia-Pacific is the fastest growing region, supported by increased investments in genomics, the adoption of precision medicine, and government support. Countries such as China and India have rapidly increased research and encouraged innovation, thus quickly expanding their bioinformatics ecosystems.

Europe is advancing bioinformatics innovation by building on a rich tradition of fundamental and translational research in genomics and molecular biology, continuous EU and national funding for genomic research, and the institutional and institutional collaboration between academic institutions, biotech companies, and publically funded institutions. The UK is at the forefront in Europe, with initiatives such as Genomics England supporting genomic data analysis.

Genomics is the popular bioinformatic application because it has widespread use in personalized medicine, diagnostics, and population genomics. Moreover, recent advances in next-gen sequencing technologies, combined with low-cost investments to develop genomes and analyze them more rapidly has made genomic data analysis the focus of the future of bioinformatics and its research applications.

Bioinformatics is being used to provide personalized medicine through the utilization of genomic and proteomic data to provide treatments that match individual genetic profiles. Bioinformatics data analysis helps investigators provide better diagnostic specificity and a more individualized treatment option, particularly in oncology and precision diagnostics.

Global Bioinformatics Market size was valued at USD 19.51 Billion in 2024 and is poised to grow from USD 22.09 Billion in 2025 to USD 59.55 Billion by 2033, growing at a CAGR of 13.2% in the forecast period (2026–2033).

The bioinformatics market observes intense competition and innovation. Leading players, such as are Eurofins Scientific, Thermo Fisher Scientific, Inc., and Illumina, Inc., have been adopting strategies centred around integration of technological advances and strategic collaborations. Companies like Qiagen, Agilent Technologies, My Intelligent Machines (MIMs), and LatchBio are using their innovative tools such as QIAGEN’s Microbiome WGS SeqSets and Agilent’s oncology-focused partnership with Theragen Bio. This helps them to improve the precision and efficiency. Many firms are also entering strategic R&D partnerships. Few such instances were seen in Illumina’s alliance with AstraZeneca and Thermo Fisher’s startup incubator collaboration in 2022. These efforts were made to expand the companies’ research capabilities; make bioinformatics tools democratized and gain competitive advantage in the market. Startups are also entering the market to take advantage of its growth. 'Thermo Fisher Scientific, Inc. (United States)', 'Eurofins Scientific SE (Luxembourg)', 'Illumina, Inc. (United States)', 'Revvity Inc (United States)', 'Qiagen N.V. (Netherlands)', 'Agilent Technologies, Inc. (United States)', 'DNASTAR, Inc. (United States)', 'Waters Corporation (United States)', 'Azenta, Inc. (United States)', 'MedGenome Labs Ltd. (India)', 'Fios Genomics (United Kingdom)', 'Genscript Biotech Corporation (China)', 'Dotmatics (United States)', 'Dnanexus, Inc. (United States)', 'Synbio Technologies (United States)', 'NeoGenomics Laboratories (United States)', 'Limerston Capital (Source BioScience) (United Kingdom)', 'Psomagen, Inc. (formerly Macrogen Corp.) (United States / South Korea)', 'LabVantage Solutions, Inc. (Biomax Informatics AG) (United States)', 'Sophia Genetics (Switzerland)'

The increase in regulatory approvals of novel drugs from regulatory bodies such as FDA and Center for Drug Evaluation and Research fuels the demand for bioinformatics solutions. In 2023 alone, the CDER approved 55 novel drugs. This is the second-highest number of approvals in a single year. This increase in approvals shows that the market is progressive towards drug development. This, in turn, indicates the presence of a suitable environment for innovation and market entry. The increased number of FDA approvals directly correlates with heightened research and development (R&D) activities. This creates a direct demand for advanced databases and software tools. Thus, the role of bioinformatics in this transformative journey is more evident now than ever before.

There has been a shift of consumer preference towards subscription-based and pay-per-use models. Companies like Qiagen and Genentech are providing their users access to software and analysis tools through different flexible and affordable subscription plans. This is departing from the traditional upfront licensing fees. This model promotes accessibility and provides cost-effective and adaptable solutions.

As per the 2024 bioinformatics market regional forecast, the North American market is predicted to hold the largest share among all regions in 2024. The region holds 43% of the total market share in 2024. The high spending the region observes on healthcare along with factors such as presence of leading biotech and pharmaceutical companies in the region and strong government funding all contribute to its growth. The high concentration of genomic research initiatives also continues to spur adoption in the region. The US emerges as the hub for bioinformatics in the region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Bioinformatics Market
Bioinformatics Market

Report ID: SQMIG35J2131

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE